Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Harvest One Cannabis Inc. (V:HVT)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for HVT within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Nov 12, 2020 08:00 ET
Harvest One Subsidiary Satipharm Granted US Patent Covering Gelpell(TM) Technology
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2020) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQX: HRVOF) ("Harvest One" or the "Company") announced today that the United States Patent and Trademark Office has granted its wholly-owned subsidiary Satipharm Ltd. ("Satipharm") US Pat No. 10,555,906 covering Satipharm's proprietary Gelpell™ technology.
Read full article
Oct 28, 2020 21:23 ET
Harvest One Reports Fourth and Year End Financial Results for 2020
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2020) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQX: HRVOF) ("Harvest One" or the "Company") is pleased to announce its financial results for the three and twelve months ended June 30, 2020.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.89
--
--
Price to Sales - TTM
1.80
9.27
9.65
Price to Book - most recent quarter
0.45
2.16
3.09
Price to Cash Flow per share - TTM
--
17.64
11.67
Price to Free Cash Flow per share - TTM
--
12.35
18.27
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 20208,247-90,792
Oct 31, 202099,03959,070
Oct 15, 202039,969-21,611
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Harvest One Cannabis Inc.(Harvest One) is a Canada-based company that develops and distributes health, wellness and selfcare products with a market focus on sleep, pain, and anxiety. The Company's subsidiaries include Satipharm Limited (Satipharm), Dream Water Global, and Delivra Corp. (Delivra). Satipharm is a health & wellbeing company, which is specialized in the development and manufacture of cannabinoid-based products from the cannabis plant. Dream Water Global is engaged in selling natural, 0-calorie, liquid sleep shot. Delivra manufactures and sells a line of natural topical creams with the transdermal delivery system platform under the LivRelief brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance.

See business summary

 

Twitter

Search (past week) for $HVT.CA HVT.V